Boxer Capital LLC 13D and 13G filings for Mereo BioPharma Group plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:40 pm Sale | 2021-12-31 | 13G | Mereo BioPharma Group plc MREO | Boxer Capital LLC | 4,082,576 3.600% | -6,226,674 (-60.40%) | Filing |
| 2021-02-16 4:29 pm Sale | 2020-12-31 | 13G | Mereo BioPharma Group plc MREO | Boxer Capital LLC | 10,309,250 9.100% | -10,052,625 (-49.37%) | Filing |
| 2020-06-05 4:31 pm Purchase | 2020-06-03 | 13G | Mereo BioPharma Group plc MREO | Boxer Capital LLC | 20,361,875 9.500% | 8,109,160 (+66.18%) | Filing |